IL6 and infection: We found that MSAD-1 treatment exerted enhanced productions of two inflammatory cytokines, TNF-α and IL-6 in J774A.1 cells in a dose dependent manner, suggesting that it could elicit immune response of innate cells in infection of mycobacteria.